A detailed history of Sage Capital Management, LLC transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Sage Capital Management, LLC holds 16,750 shares of ORMP stock, worth $38,692. This represents 0.02% of its overall portfolio holdings.

Number of Shares
16,750
Previous 16,750 -0.0%
Holding current value
$38,692
Previous $43 Million 5.06%
% of portfolio
0.02%
Previous 0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$2.07 - $2.83 $34,672 - $47,402
16,750 New
16,750 $43 Million

Others Institutions Holding ORMP

About ORAMED PHARMACEUTICALS INC.


  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $89.7M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Sage Capital Management, LLC Portfolio

Follow Sage Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Capital Management, LLC with notifications on news.